About this trial
Traumatic brain injury and other severe brain injuries requiring neurointensive care are associated with high mortality, long-term disability and substantial societal burden. Despite advances in critical care, outcomes after severe brain injury remain difficult to predict and secondary brain injury plays a major role in determining prognosis.
The Örebro Severe Brain Injury Database (ÖrSBID) is a prospective observational registry that aims to systematically collect detailed clinical, physiological, imaging and biological data from adult patients with severe brain injury requiring care at the neurointesive care unit or neurointermediate care unit at Örebro University Hospital.
The purpose of the registry is to enable deep phenotyping of severe brain injury, improve understanding of secondary injury mechanisms, support outcome prediction and provide a platform for longitudinal follow-up and future research. No experimental interventions are performed as part of the study.
Eligibility criteria
Qualifiers
Age > 16 years
Severe traumatic brain injury or other severe brain injury requiring neurointensive or neurointermediate care
Admission to Örebro University Hospital
Disqualifiers
Age < 16 years < 90 years
Non-survivable brain injury
Patients not requiring neurointensive or neurointermediate care
Declinced consent by patient or legal representative
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
András Zoltán Buki
Lead sponsor
Region Orebro lan
Sponsor institution